ArticleMetabolites2025

Increased Lyso-Gb1 Levels in an Obese Splenectomized Gaucher Disease Type 1 Patient Treated with Eliglustat: Unacknowledged Poor Compliance or Underlying Factors.

Evelina Maines et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.